Cargando…
Exenatide treatment causes suppression of serum fasting ghrelin levels in patients with type 2 diabetes mellitus
AIM: In the present study, we investigated the long-term effects of exenatide treatment on serum fasting ghrelin levels in patients with type 2 diabetes mellitus. METHODS: Type 2 diabetic patients, who were using metformin with and without the other antihyperglycemic drugs on a stable dose for at le...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Bioscientifica Ltd
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5776666/ https://www.ncbi.nlm.nih.gov/pubmed/29217653 http://dx.doi.org/10.1530/EC-17-0242 |